Supplementary Data for "Efficacy and Safety of Withania somnifera (Indian Ginseng) in Rheumatoid Arthritis: A Systematic Review of Evidence from Experimental Studies to Clinical Trials"

This dataset comprises supplementary material for the systematic review titled "Efficacy and Safety of Withania somnifera (Indian Ginseng) in Rheumatoid Arthritis: A Systematic Review of Evidence from Experimental Studies to Clinical Trials." The dataset includes detailed quality (risk of bias) assessments of selected studies in the review and descriptions of the clinical and pre-clinical studies evaluating the effect of W. somnifera in poly-herbal formulations in rheumatoid arthritis. Specifically, it contains:

Table S1a: Sources of risk of bias in randomized controlled trials, providing insights into potential biases that could affect the validity of these studies.
Table S1b: Sources of risk of bias in case series, highlighting factors that may impact the reliability of findings from the observational study.
Table S1c: Sources of risk of bias in animal studies, detailing the methodological quality and potential biases in pre-clinical research.
Table S2a: Clinical studies of W. somnifera in combination with other interventions (polytherapy), summarizing the therapeutic regimens, patient populations, and key findings.
Table S2b: Pre-clinical studies involving W. somnifera in combination with other interventions (polytherapy), outlining the study designs, interventions, and outcomes.
The dataset is intended to enhance transparency and reproducibility in the assessment of efficacy and safety of W. somnifera in rheumatoid arthritis treatment.

本数据集为题为《睡茄（Withania somnifera，印度人参）治疗类风湿关节炎（Rheumatoid Arthritis）的疗效与安全性：从实验研究到临床试验证据的系统综述》的系统综述的补充材料。本数据集包含该综述中纳入研究的详细质量（偏倚风险，risk of bias）评估内容，以及针对类风湿关节炎患者、评价睡茄多草药制剂（poly-herbal formulations）疗效的临床与临床前（pre-clinical）研究的相关描述。具体而言，本数据集涵盖以下内容：
表S1a：随机对照试验的偏倚风险来源，阐明可能影响此类研究效度的潜在偏倚因素。
表S1b：病例系列研究的偏倚风险来源，明确可能影响该观察性研究结果可靠性的相关因素。
表S1c：动物实验的偏倚风险来源，详细阐述临床前研究的方法学质量与潜在偏倚。
表S2a：睡茄联合其他干预措施（联合疗法，polytherapy）的临床研究，汇总了治疗方案、受试人群与核心研究结果。
表S2b：涉及睡茄联合其他干预措施（联合疗法）的临床前研究，梳理了研究设计、干预手段与观测结局。
本数据集旨在提升睡茄治疗类风湿关节炎的疗效与安全性评估的透明度与可重复性。